Cargando…
Clinical Significance of BTLA, CD27, CD70, CD28 and CD80 as Diagnostic and Prognostic Markers in Ovarian Cancer
It is very important to find new diagnostic and prognostic biomarkers. A total of 79 patients were enrolled in the study. The study group consisted of 37 patients with epithelial ovarian cancer, and the control group consisted of 42 patients with benign ovarian lesions. Five proteins involved in the...
Autores principales: | Świderska, Janina, Kozłowski, Mateusz, Gaur, Maria, Pius-Sadowska, Ewa, Kwiatkowski, Sebastian, Machaliński, Bogusław, Cymbaluk-Płoska, Aneta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8871082/ https://www.ncbi.nlm.nih.gov/pubmed/35204342 http://dx.doi.org/10.3390/diagnostics12020251 |
Ejemplares similares
-
Clinical Relevance of Soluble Forms of Immune Checkpoint Molecules sPD-1, sPD-L1, and sCTLA-4 in the Diagnosis and Prognosis of Ovarian Cancer
por: Świderska, Janina, et al.
Publicado: (2022) -
Could Vaspin Be a Potential Diagnostic Marker in Endometrial Cancer?
por: Pietrzyk, Dominika, et al.
Publicado: (2023) -
Could Galectin 3 Be a Good Prognostic Factor in Endometrial Cancer?
por: Cymbaluk-Płoska, Aneta, et al.
Publicado: (2020) -
Evaluation of Paraoxonase-1 and Pentraxin-3 in the Diagnosis and Prognosis of Endometrial Cancer
por: Kozłowski, Mateusz, et al.
Publicado: (2022) -
Immunotherapy of Ovarian Cancer with Particular Emphasis on the PD-1/PDL-1 as Target Points
por: Świderska, Janina, et al.
Publicado: (2021)